These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. A new disc technique for drug sensitivity test of tubercle bacilli. Kudoh S; Kudoh T; Yoshikawa S Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376 [No Abstract] [Full Text] [Related]
66. [Studies on antituberculous activity of lividomycin in vitro]. Horai Z; Shimizu K; Yamamoto K; Fujisawa Y; Yamashita K Kekkaku; 1971 Oct; 46(10):401-4. PubMed ID: 5004573 [No Abstract] [Full Text] [Related]
67. [Action in vitro of antibacillar drug combinations on pluriresistant strains of tubercle bacilli]. Kreis B; Fournaud S Rev Tuberc Pneumol (Paris); 1966 Apr; 30(4):445-60. PubMed ID: 4958256 [No Abstract] [Full Text] [Related]
68. [Observations on patients with primary drug resistance of the Mycobacterium tuberculosis]. Prosvirnov KP; Korol' II; Dobrovol'skaia GI Probl Tuberk; 1972; 50(1):82-4. PubMed ID: 4622059 [No Abstract] [Full Text] [Related]
69. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis]. Kuang T; Jin G; Song P; Li W; Wang Z Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378 [TBL] [Abstract][Full Text] [Related]
70. Drug resistance among Mycobacterium tuberculosis strains in immigrants: is there a real threat everywhere? Esteban J; Granizo JJ; Alvarez-Castillo MC; Soriano F Clin Microbiol Infect; 2004 Apr; 10(4):335-6. PubMed ID: 15059124 [TBL] [Abstract][Full Text] [Related]
71. [Effect of 4-chloroanilid of 5-chlorosalicylic acid on the viability of tubercle bacilli in vitro]. Kostrzeński W; Paklerska-Pobratyn H Gruzlica; 1968 Feb; 36(2):161-4. PubMed ID: 4969840 [No Abstract] [Full Text] [Related]
72. [Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years]. Daddi G; Lucchesi M; Maldarizzi B; Mancini P; Termine A Ann Ist Carlo Forlanini; 1969; 29(4):286-300. PubMed ID: 5004328 [No Abstract] [Full Text] [Related]
73. [Incidence of resistant mutants of Mycobacterium tuberculosis (MT) strains from different areas of Rumania. Bacteriological study--epidemiological aspects]. Anastasatu C; Băicoianu S; Teodorescu A Arch Roum Pathol Exp Microbiol; 1970; 29(1):212-22. PubMed ID: 4998673 [No Abstract] [Full Text] [Related]
74. [Experimental studies in vitro on the antituberculous activities of 27753 (R.P), a semisynthetic derivative of griselimycine. II. Antituberculous activities of R.P. in combination with other antituberculous agents]. Shibata A Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):32-7. PubMed ID: 6442173 [No Abstract] [Full Text] [Related]
75. Prevalence of acquired MDR-TB and HIV co-infection. Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236 [TBL] [Abstract][Full Text] [Related]
76. [Primary resistance of Mycobacterium tuberculosis (based on data of a regional dispensary)]. Moskalev LK Probl Tuberk; 1969; 47(3):63-6. PubMed ID: 4982180 [No Abstract] [Full Text] [Related]
77. [Drug resistance of Mycobacterium tuberculosis in patients with serous exudative pleurisy]. Tiukhtin NS; Berlova ZD; Gned'ko VI Probl Tuberk; 1976; (8):66-9. PubMed ID: 826903 [No Abstract] [Full Text] [Related]
78. [Comparison of laboratory and clinical antitubercular agent sensitivity tests]. Popovic J; Praso R; Stosic Z; Davidovic C Plucne Bolesti Tuberk; 1971; 23(4):333-8. PubMed ID: 5004987 [No Abstract] [Full Text] [Related]
79. [Sensitivity to 2d line preparations of Mycobacterium tuberculosis resistant to 1st line preparations]. Kozulitsyna TI; Golyshevskaia VI Probl Tuberk; 1972; 50(11):62-6. PubMed ID: 4630566 [No Abstract] [Full Text] [Related]